Proteinuria is a defining feature of focal segmental glomerulosclerosis, typically accompanied by hypoalbuminemia, hypercholesterolemia, and peripheral edema. The nephrotic syndrome in children is ...

Figure 1: suPAR measurement in the serum of subjects with glomerular disease. To determine whether suPAR is a cause or a consequence of FSGS, we established three different mouse models: (i) uPAR ...

Moderator Sagar Nigwekar, MD, of Massachusetts General Hospital in Boston, is joined by Edgar Lerma, MD, of the University of ...

Focal segmental glomerulosclerosis (FSGS), a histopathological lesion triggered by podocyte injury, is a leading cause of kidney failure worldwide, 1,2 yet no treatment has been approved for this ...

Opening of Japan’s first clinical trial site for ACTION3 triggers the first development milestone payment of ¥400 million ...

Glomerulosclerosis refers to the scarring of the glomeruli in the kidneys following any type of insult. The glomeruli are the tiny loops of capillaries that rest on the special basement membrane ...

slope compared with irbesartan among patients with focal segmental glomerulosclerosis (FSGS), the phase III DUPLEX trial showed. At the final analysis, the between-group differences in the primary ...

Focal segmental glomerulosclerosis (FSGS) is a rare kidney disorder that affects children and adults, and can lead to kidney failure. New findings from a team led by the University of Minnesota ...

The global focal segmentmental glomerulosclerosis (FSGS) treatments market sales is expected to expand at a compound annual growth rate (CAGR) of 5% between 2023 and 2033, from US$ 3 billion in 2023 ...

DelveInsight’s “Focal Segmental Glomerulosclerosis Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Focal Segmental ...

This page lists all known medications that could potentially lead to 'Focal segmental glomerulosclerosis' as a side effect. It's important to note that mild side effects are quite common with ...